Nucleic Acids as Biotools at the Interface between Chemistry and Nanomedicine in the COVID-19 Era(110 views) Borbone N, Piccialli I, Falanga AP, Piccialli V, Roviello GN, Oliviero G
International Journal Of Molecular Sciences, 2022 Jun; 23: 4359-4375.
Nicola Borbone 1, Ilaria Piccialli 2, Andrea Patrizia Falanga 1, Vincenzo Piccialli 3, Giovanni N. Roviello 4,*and Giorgia Oliviero 51 Department of Pharmacy, University of Naples Federico II, Via Domenico Montesano 49,80131 Naples, Italy; nicola.borbone@unina.it (N.B.); andreapatrizia.falanga@unina.it (A.P.F.)2 Division of Pharmacology, Department of Neuroscience, Reproductive and Odontostomatological Sciences,University of Naples Federico II, Via Sergio Pansini 5, 80131 Naples, Italy; ilaria.piccialli@unina.it3 Department of Chemical Sciences, University of Naples Federico II, Via Cintia 26, 80126 Naples, Italy;vinpicci@unina.it4 Institute of Biostructures and Bioimaging, Italian National Council for Research (IBB-CNR),Area di Ricerca Site and Headquarters, Via Pietro Castellino 111, 80131 Naples, Italy5 Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II,Via Sergio Pansini 5, 80131 Naples, Italy; giorgia.oliviero@unina.it*
Correspondence: GN Roviello giroviel@unina.it
References: Not available.
Nucleic Acids as Biotools at the Interface between Chemistry and Nanomedicine in the COVID-19 Era
Abstract: The recent development of mRNA vaccines against the SARS-CoV-2 infection has turned
the spotlight on the potential of nucleic acids as innovative prophylactic agents and as diagnostic
and therapeutic tools. Until now, their use has been severely limited by their reduced half-life in the
biological environment and the difficulties related to their transport to target cells. These limiting
aspects can now be overcome by resorting to chemical modifications in the drug and using appropriate nanocarriers, respectively. Oligonucleotides can interact with complementary sequences of
nucleic acid targets, forming stable complexes and determining their loss of function. An alternative
strategy uses nucleic acid aptamers that, like the antibodies, bind to specific proteins to modulate
their activity. In this review, the authors will examine the recent literature on nucleic acids-based
strategies in the COVID-19 era, focusing the attention on their applications for the prophylaxis of
COVID-19, but also on antisense- and aptamer-based strategies directed to the diagnosis and therapy of the coronavirus pandemic
Nucleic Acids as Biotools at the Interface between Chemistry and Nanomedicine in the COVID-19 Era
No results.
Nucleic Acids as Biotools at the Interface between Chemistry and Nanomedicine in the COVID-19 Era